ReviewSeminars in interventional radiology2019
Complications of Percutaneous Renal Biopsy.
Review in Seminars in interventional radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effect of Preprocedural Desmopressin on Complications after Kidney Biopsy: A Systematic Review and Meta-Analysis.Kidney360 · 2026Pooled it
- Effect of desmopressin on bleeding outcomes after native renal biopsy: a systematic review and meta-analysis.Scientific reports · 2025Pooled it
- Diagnostic Performance of [Diagnostics (Basel, Switzerland) · 2026Article
- Integrated Serum and Urinary Metabolomics Reveal Distinct Signatures of Kidney Graft Function-A Single-Center Cohort Study.Biomedicines · 2026Article
- Percutaneous Kidney Biopsy: Indications, Technique, and Peri-Procedural Management-A Narrative Review.Diagnostics (Basel, Switzerland) · 2026Review
- Acute left ovarian vein thrombosis following percutaneous renal biopsy: A case report.Radiology case reports · 2026Article
- Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy.Kidney medicine · 2026Review
- Bleeding risk and prediction model to predict bleeding risk of tissue biopsy for definitive diagnosis in patients with suspected amyloidosis.Annals of medicine · 2025Article
- Article
- What Is the Safe Observation Period Following Image-Guided Percutaneous Renal Biopsies?Journal of medical imaging and radiation oncology · 2025Article
- Use of Injection of Hemostatic Gelfoam Mixture During Percutaneous Core Biopsy for Renal Tumors: A Comparative Retrospective Study of Outcomes Regarding Bleeding Complications, Hospital Stay, and Diagnostic Yield Accuracy.Diagnostics (Basel, Switzerland) · 2025Article
- Diagnostic Pitfalls of the Bleeding Origin after a Percutaneous Renal Biopsy.Internal medicine (Tokyo, Japan) · 2025Article
- What can go wrong when doing right? A pictorial review of iatrogenic genitourinary complications.Abdominal radiology (New York) · 2024Review
- Computed tomography-guided percutaneous biopsy in diagnosis of suspected metastatic renal cell carcinoma: which location is the most suitable?Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2024Article
- Article
- Article
- Cost-Effectiveness Analysis of the Clear Cell Likelihood Score Against Renal Mass Biopsy for Evaluating Small Renal Masses.Urology · 2024Article
- Clinicopathological Pattern of Renal Biopsies in Children with Nephrotic Syndrome.Clinical medicine & research · 2024Article
- New Insights into Pediatric Kidney Transplant Rejection Biomarkers: Tissue, Plasma and Urine MicroRNAs Compared to Protocol Biopsy Histology.International journal of molecular sciences · 2024Article
- Effect of music therapy intervention on anxiety and pain during percutaneous renal biopsy: a randomized controlled trial.Clinical kidney journal · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous renal biopsy is widely used for diagnosis, prognosis, and management of nephropathies. Complications may arise after renal biopsy, most commonly in the form of bleeding. Efforts should be taken to optimize modifiable risk factors such as hypertension, thrombocytopenia, and coagulopathy prior to the procedure. Unmodifiable risk factors such as poor renal function, gender, and underlying histologic diagnosis may be used to identify high-risk patients. Delayed presentation of bleeding complications is common, and close clinical follow-up is crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.